
Cytonics
Developer of a diagnostic therapeutics drug designed to improve the treatment of painful osteoarthritis, back, and joint pain. The company's drug offers a Fibronectin-Aggrecan Complex Test for molecul...
Valuation
$104.1M
Latest known
Share Price
N/A
Total Raised
$39.6M
Last Round
N/A